- Drug Manufacturers - General
- Healthcare
Bristol-Myers Squibb Company
BMY · US ·
NYSE
42.67
USD
+0.03
(0.07%)
-
-3.04
EPS
-
-14.04
P/E
-
86.5B
MARKET CAP
-
5.55%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -2.88 | 0.632 | 6.63 | 6.08 | 6.66 | 6.25 | 33.04% |
| Avg. Estimate | -3 | 0.519 | 5.18 | 5.27 | 6.44 | 6.05 | 32.07% |
| Low Estimate | -3.1 | 0.415 | 2.76 | 2.71 | 6.2 | 5.82 | 31.15% |
| No. Of Analysts | 16 | 18 | 15 | 9 | 7 | 4 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 45.9B | 46.8B | 47.4B | 44.7B | 45.4B | 42.1B | -1.70% |
| Avg. Estimate | 45.5B | 46B | 46.1B | 43.6B | 44.3B | 41B | -2.05% |
| Low Estimate | 45.1B | 45.6B | 45.2B | 42.3B | 43B | 39.8B | -2.46% |
| No. Of Analysts | 19 | 16 | 18 | 20 | 10 | 9 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -4.92B | 1.31B | 13.8B | 12.6B | 13.8B | 13B | 35.94% |
| Avg. Estimate | -6.15B | 1.08B | 10.2B | 10.1B | 13.4B | 12.6B | 32.25% |
| Low Estimate | -7.38B | 863M | 5.74B | 5.63B | 12.9B | 12.1B | 29.49% |
| No. Of Analysts | 19 | 16 | 18 | 20 | 10 | 9 |